Abstract
Blockade of tumour necrosis factor (TNF) is an effective treatment in rheumatoid arthritis (RA), but both non-responders and partial responders are quite frequent. This suggests that other pro-inflammatory cytokines may be of importance in the pathogenesis of RA and as possible targets for therapy. In this study we investigated the effect of TNF blockade (infliximab) on the synovial expression of IL-15 in RA in relation to different cell types and expression of other cytokines, to elucidate whether or not IL-15 is a possible target for therapy, independently of TNF blockade. Two arthroscopies with multiple biopsies were performed on nine patients with RA and knee-joint synovitis before and after three infusions of infliximab (3 mg/kg). Synovial biopsies were analysed with immunohistochemistry for expression of IL-15, TNF, IL-1alpha, IL-1ss and IFN-gamma, and for the cell surface markers CD3, CD68 and CD163. Stained synovial biopsy sections were evaluated by computerized image analysis. IL-15 expression was detected in all synovial biopsies taken at baseline. After infliximab therapy, the expression of IL-15 was increased in four patients and reduced in five. Synovial expression of IL-15 was not correlated with any CD marker or ...Continue Reading
References
Aug 1, 1995·Annals of the Rheumatic Diseases·A K UlfgrenU Andersson
Feb 1, 1996·Nature Medicine·I B McInnesF Y Liew
Jul 1, 1996·Arthritis and Rheumatism·P P TakR N Maini
Feb 1, 1997·Nature Medicine·I B McInnesF Y Liew
Apr 1, 1997·The Journal of Pathology·E W ThurkowP P Tak
Apr 29, 1998·The Journal of Clinical Investigation·N Oppenheimer-MarksP E Lipsky
Jan 6, 2000·Lancet·R MainiP Lipsky
Feb 9, 2000·Rheumatology·M C KraanP P Tak
Jun 2, 2000·Annals of the Rheumatic Diseases·A K UlfgrenU Andersson
Sep 8, 2000·Annals of the Rheumatic Diseases·K Masuko-HongoT Kato
Nov 18, 2000·Arthritis and Rheumatism·A K UlfgrenP C Taylor
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Jul 13, 2002·Arthritis and Rheumatism·E William St ClairEdward C Keystone
Jul 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Veronika GrohThomas Spies
Aug 9, 2003·Arthritis and Rheumatism·Tom J M SmeetsPaul-Peter Tak
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mousa Komai-KomaFoo Y Liew
Mar 17, 2004·Arthritis and Rheumatism·Mi-La ChoHo-Youn Kim
Jan 11, 2005·Arthritis and Rheumatism·Anca Irinel CatrinaAnn Kristin Ulfgren
Sep 6, 2005·Arthritis and Rheumatism·Bo BaslundIain B McInnes
Citations
Dec 1, 2006·Arthritis Research & Therapy·Johan LindbergJoakim Lundeberg
Mar 19, 2008·Arthritis Research & Therapy·Erik SundbergUlf Andersson
Mar 7, 2009·Arthritis Research & Therapy·Ravi C DwivediHani S El-Gabalawy
Jul 14, 2012·PloS One·Marta Benito-MiguelMaría-Eugenia Miranda-Carús
Nov 14, 2013·PloS One·Tiantian ZhangXiaohua Mao
Oct 15, 2009·Rheumatology International·Hajime YamanakaKazutoshi Miyamoto
Jan 12, 2010·Rheumatology International·Tetsuya IchikawaYukio Koide
May 17, 2008·Scandinavian Journal of Immunology·A K AnderssonF M Brennan
Nov 28, 2016·Experimental Biology and Medicine·Etheresia PretoriusDouglas B Kell
Aug 16, 2006·European Journal of Immunology·Marion von GeldernChristine S Falk
May 23, 2013·Physiological Genomics·Max BrennerPércio S Gulko
Apr 4, 2021·Life·Daniil ShevyrevVladimir Kozlov
Jul 30, 2021·International Journal of Rheumatic Diseases·Robert W Ike, Kenneth C Kalunian